NFKB1 and B-cell chronic lymphocytic leukemia: These alterations trigger dominant NF-κB activation and PI3K stimulation that are typical of the activated B cell (ABC) subtype of diffuse large B cell lymphoma (DLBCL) as well as mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) (23).